RT Journal Article
SR Electronic
T1 762 A first-in-human phase 1 clinical study evaluating safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the EDB+FN targeting ADC PYX-201 in participants with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A857
OP A857
DO 10.1136/jitc-2023-SITC2023.0762
VO 11
IS Suppl 1
A1 Wilks, Sharon
A1 Carneiro, Benedito
A1 Cote, Gregory
A1 Henry, Jason
A1 Sen, Shiraj
A1 Spira, Alexander I
A1 Tsai, Frank Yung-Chin
A1 Wang, Judy S
A1 Crochiere, Marsha
A1 He, Shui
A1 Smyrnios, Sondra
A1 Unadkat, Dipali
A1 Zhang, Bin
A1 Tolcher, Anthony W
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A857.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.